...
首页> 外文期刊>Current opinion in ophthalmology >Subconjunctival microinvasive glaucoma surgeries: an update on the Xen gel stent and the PreserFlo MicroShunt
【24h】

Subconjunctival microinvasive glaucoma surgeries: an update on the Xen gel stent and the PreserFlo MicroShunt

机译:亚细胞微生物vasiveLucoma手术:Xen Gel支架的更新和Preserflo MicroShunt

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose of review This review will provide an update on surgical techniques, outcomes, and complications for two new translimbal bleb-forming surgical glaucoma devices. Recent findings The XEN Gel Microstent and PreserFlo MicroShunt comprise a category of subconjunctival microinvasive glaucoma surgery developed with the aim of improving the predictability and safety profile of bleb-forming procedures. Both devices are made of noninflammatory material which limits postsurgical inflammation and scarring and have a valve-less intrinsic flow-limiting design, which decreases the risk of hypotony. There are various techniques of implantation for the XEN Gel Microstent each with their own advantages and disadvantages. These devices have demonstrated promising outcomes in early experimental literature with similar intraocular pressure-lowering effects to traditional incisional surgery such as trabeculectomy or tube shunt surgery, but with fewer risks. Future randomized, prospective studies should be done to compare these gel stents and microshunts both to each other and to other traditional glaucoma surgeries.
机译:审查目的本综述将提供有关两种新的二手型BLEB形成外科胶质瘤设备的手术技术,结果和并发症的更新。最近发现Xen Gel Microstent和Preserflo Microshunt包括一类亚核预陈微生物型青光眼手术,其目的是改善BLEB成型程序的可预测性和安全性。这两种装置都由非炎症材料制成,这些材料限制了后勤炎症和瘢痕形成,并且具有瓣膜内固有的流量限制性设计,这降低了低间断的风险。对于Xen凝胶Microstent有各种各样的植入技术,每个植入具有自身的优点和缺点。这些装置在早期的实验文献中表现出具有类似的眼内压力降低效应的早期实验文献,与传统的切口手术等特异性切除术或管道分流手术,但风险较少。应完成未来的,前瞻性研究,以比较这些凝胶支架和微小彼此以及其他传统的青光眼手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号